During the past decade, RASF - Clinical Research Center conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 17 clinical trials were completed, i.e. on average, 130.8% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 14 clinical trials were completed. i.e. 700% of trials that started reached the finish line.

Out of the total clinical trials conducted in "RASF - Clinical Research Center" #1 sponsor was "Genentech, Inc." with 5 trials, followed by "Galapagos NV" with 4 trials sponsored, "Pfizer" with 3 trials sponsored, "R-Pharm International, LLC" with 3 trials sponsored and "Shire" with 3 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "RASF - Clinical Research Center" #1 collaborator was "OCT Clinical Trials" with 3 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator and "IQVIA Pvt. Ltd" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "RASF - Clinical Research Center" are "Rheumatoid Arthritis" (12 trials), "Arthritis, Rheumatoid" (2 trials), "Osteoarthritis, Hip" (2 trials), "Osteoarthritis, Knee" (2 trials) and "Osteoporosis" (2 trials). Many other conditions were trialed in "RASF - Clinical Research Center" in a lesser frequency.

Most popular intervention types in "RASF - Clinical Research Center" are "Drug" (20 trials), "Biological" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "GDC-0853" (4 trials), "GLPG1690" (2 trials), "Methotrexate" (2 trials) and "Tanezumab 2.5 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "RASF - Clinical Research Center" are 20 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "RASF - Clinical Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in RASF - Clinical Research Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in RASF - Clinical Research Center, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".